{
  "abstract": "Steatotic liver disease (SLD) is an umbrella term mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-associated liver disease (ALD). 1 This redefinition goes beyond terminology and reflects biological reality as these entities represent a continuous spectrum rather than fixed diagnoses, arising from two dynamic exposures (ie, alcohol intake and metabolic dysfunction) that fluctuate over time and enable interconversion.2",
  "authors": [
    {
      "affiliations": [
        "Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité - Universitätsmedizin Berlin, Berlin, Germany",
        "Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, the First Hospital of Jilin University, Changchun, People's Republic of China"
      ],
      "name": "Lanlan Chen"
    },
    {
      "affiliations": [
        "Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité - Universitätsmedizin Berlin, Berlin, Germany",
        "Berlin Institute of Health at Charité – Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany"
      ],
      "name": "Paul Horn"
    },
    {
      "affiliations": [
        "Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité - Universitätsmedizin Berlin, Berlin, Germany"
      ],
      "name": "Frank Tacke"
    }
  ],
  "title": "From static labels to dynamic trajectories: MASLD–MetALD–ALD as a dynamic continuum within the framework of steatotic liver disease",
  "uid": "4015c482-711e-5880-98e9-7c5f2654b3ce"
}